US Pharma MarketingDimension seeks up to $750M for third life sciences fund after portfolio hot streak
Dimension Capital, an investment firm focused on the convergence of machine learning and life sciences, is raising its third fund and seeking up to $750 million. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and…
Dimension Capital, an investment firm focused on the convergence of machine learning and life sciences, is raising its third batch of capital and seeking up to $750 million.
The New York and San Francisco firm ...
Source: Endpoints News